a public good project by the
Synthesis
Company
of California

© 2026

Tung‐Hung Su | doi.page

0 works0 citations0 h-index

Tung‐Hung Su

National Taiwan University(TW)National Taiwan University Hospital(TW)Hebei University(CN)

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Hepatitis B Virus Studies, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation

Most-Cited Works

→ High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load(2012)577 cited
→ Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads(2012)256 cited
→ Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients(2016)219 cited
→ Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters(2011)212 cited
→ Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation(2018)205 cited
→ Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)(2021)178 cited

→ Determinants of Spontaneous Surface Antigen Loss in Hepatitis B E Antigen–Negative Patients With A Low Viral Load(2011)151 cited

→ High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load(2019)123 cited

→ Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers(2014)111 cited

→ Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis(2013)97 cited